NRM

gene
On this page

Also known as NRM29

Summary

NRM (nurim, HGNC:8003) is a protein-coding gene on chromosome 6p21.33, encoding Nurim (Q8IXM6).

The protein encoded by this gene contains transmembrane domains and resides within the inner nuclear membrane, where it is tightly associated with the nucleus. This protein shares homology with isoprenylcysteine carboxymethyltransferase enzymes. Alternative splicing results in multiple transcript variants that encode different protein isoforms.

Source: NCBI Gene 11270 — RefSeq curated summary.

At a glance

  • GWAS associations: 22
  • Clinical variants (ClinVar): 32 total
  • MANE Select transcript: NM_001384369

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:8003
Approved symbolNRM
Namenurim
Location6p21.33
Locus typegene with protein product
StatusApproved
AliasesNRM29
Ensembl geneENSG00000137404
Ensembl biotypeprotein_coding
OMIM620017
Entrez11270

Gene structure

Transcript identifiers

Ensembl transcripts: 12 — 7 protein_coding, 5 protein_coding_CDS_not_defined

ENST00000259953, ENST00000376420, ENST00000376421, ENST00000444096, ENST00000462857, ENST00000470733, ENST00000474864, ENST00000482141, ENST00000495946, ENST00000866727, ENST00000921005, ENST00000921006

RefSeq mRNA: 6 — MANE Select: NM_001384369 NM_001270707, NM_001270708, NM_001270709, NM_001270710, NM_001384369, NM_007243

CCDS: CCDS4686, CCDS59498

Canonical transcript exons

ENST00000376421 — 4 exons

ExonStartEnd
ENSE000016733813068804930688942
ENSE000016923013069004730690243
ENSE000022390273069084230690984
ENSE000035416123068927630689452

Expression profiles

Bgee: expression breadth ubiquitous, 136 present calls, max score 90.86.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 28.8090 / max 178.4199, expressed in 1794 samples.

FANTOM5 promoters (2 alternative TSS)

Promoter IDTPM avgSamples expressed
7258228.53001794
725810.2790116

Top tissues by expression

137 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
embryoUBERON:000092290.86gold quality
ganglionic eminenceUBERON:000402390.86gold quality
bloodUBERON:000017890.28gold quality
granulocyteCL:000009489.60gold quality
body of uterusUBERON:000985388.99gold quality
descending thoracic aortaUBERON:000234588.72gold quality
ectocervixUBERON:001224988.63gold quality
ventricular zoneUBERON:000305387.99gold quality
leukocyteCL:000073887.94gold quality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099187.84gold quality
monocyteCL:000057687.62gold quality
apex of heartUBERON:000209887.62gold quality
thoracic aortaUBERON:000151587.29gold quality
ascending aortaUBERON:000149687.17gold quality
myometriumUBERON:000129687.13gold quality
endocervixUBERON:000045886.90gold quality
left uterine tubeUBERON:000130386.78gold quality
uterine cervixUBERON:000000286.47gold quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047386.28gold quality
right ovaryUBERON:000211886.14gold quality
right coronary arteryUBERON:000162586.04gold quality
placentaUBERON:000198786.04gold quality
smooth muscle tissueUBERON:000113585.98gold quality
mucosa of transverse colonUBERON:000499185.98gold quality
left coronary arteryUBERON:000162685.93gold quality
right lungUBERON:000216785.86gold quality
stromal cell of endometriumCL:000225585.60gold quality
vaginaUBERON:000099685.55gold quality
popliteal arteryUBERON:000225085.40gold quality
tibial arteryUBERON:000761085.39gold quality

Single-cell (SCXA)

Detected in 2 experiment(s), a significant marker in 0.

ExperimentMarker?Max mean expression
E-MTAB-4850no292.43
E-ANND-3no2.28

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

27 targeting NRM, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-671-5P99.5267.111277
HSA-MIR-513C-5P99.5068.421730
HSA-MIR-514B-5P99.5068.191766
HSA-MIR-569799.3967.741249
HSA-MIR-431699.3765.751360
HSA-MIR-6731-5P99.2867.422375
HSA-MIR-808599.2867.562362
HSA-MIR-569399.2466.671106
HSA-MIR-3074-5P98.8266.561414
HSA-MIR-471098.6165.961048
HSA-MIR-138-5P98.4370.491292
HSA-MIR-541-5P98.2467.771181
HSA-MIR-1233-5P98.1966.711201
HSA-MIR-6778-5P98.1966.591239
HSA-MIR-3664-3P97.8567.621452
HSA-MIR-7855-5P97.3967.18925
HSA-MIR-194-3P97.3665.961027
HSA-MIR-227897.3066.191130
HSA-MIR-4800-5P97.2265.91324
HSA-MIR-3184-3P96.9666.91845
HSA-MIR-61796.7965.96738
HSA-MIR-391896.1364.651300
HSA-MIR-6734-5P95.7065.56950
HSA-MIR-659-5P95.3665.00300
HSA-MIR-286195.2465.471056
HSA-MIR-319794.0263.4785
HSA-MIR-444492.6767.9256

Literature-anchored findings (GeneRIF, showing 2)

  • nurim is a polytopic protein tightly associated with the inner nuclear membrane (PMID:15542857)
  • these findings implicate that the inner nuclear membrane protein Nurim plays an important role in the suppression of apoptosis (PMID:23092226)

Cross-species orthologs

3 orthologs

OrganismSymbolGene ID
danio_rerionrmENSDARG00000063690
mus_musculusNrmENSMUSG00000059791
drosophila_melanogasterCG7655FBGN0038536

Protein

Protein identifiers

NurimQ8IXM6 (reviewed: Q8IXM6)

Alternative names: Nuclear envelope membrane protein, Nuclear rim protein

All UniProt accessions (3): Q8IXM6, A0A1U9X845, H0Y6T6

UniProt curated annotations — full annotation on UniProt →

Subcellular location. Nucleus inner membrane.

Similarity. Belongs to the nurim family.

Isoforms (3)

UniProt IDNamesCanonical?
Q8IXM6-11, ayes
Q8IXM6-22, b
Q8IXM6-63, c

RefSeq proteins (6): NP_001257636, NP_001257637, NP_001257638, NP_001257639, NP_001371298, NP_009174 (=MANE)

Domains & families (InterPro)

IDNameType
IPR033580Nurim-likeFamily

UniProt features (17 total): topological domain 7, transmembrane region 6, splice variant 3, chain 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q8IXM6-F189.620.68

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 126 (showing top): GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_DN, PATIL_LIVER_CANCER, FUJII_YBX1_TARGETS_DN, MODULE_397, GOCC_NUCLEAR_ENVELOPE, GOCC_ORGANELLE_INNER_MEMBRANE, MARSON_BOUND_BY_E2F4_UNSTIMULATED, GOCC_NUCLEAR_INNER_MEMBRANE, GOCC_NUCLEAR_MEMBRANE, GOCC_ORGANELLE_ENVELOPE, FEVR_CTNNB1_TARGETS_DN, VANOEVELEN_MYOGENESIS_SIN3A_TARGETS, CRX_DN.V1_UP, CRX_NRL_DN.V1_UP, RB_P107_DN.V1_UP

GO Biological Process (0):

GO Molecular Function (1): protein binding (GO:0005515)

GO Cellular Component (5): nuclear envelope (GO:0005635), nuclear inner membrane (GO:0005637), membrane (GO:0016020), nuclear membrane (GO:0031965), nucleus (GO:0005634)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
nucleus2
binding1
endomembrane system1
organelle envelope1
organelle inner membrane1
nuclear membrane1
cellular anatomical structure1
nuclear envelope1
organelle membrane1
intracellular membrane-bounded organelle1

Protein interactions and networks

STRING

538 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
NRMLBRQ14739645
NRMEMDP50402621
NRMLEMD3Q9Y2U8575
NRMLMNB1P20700554
NRMLMNB2Q03252551
NRMSUN2Q9UH99540
NRMC6orf136Q5SQH8518
NRMSUN1O94901488
NRMSUN3Q8TAQ9452
NRMGNL1P36915448
NRMTCF19Q9Y242435
NRMGTF2H4Q92759429
NRMABCF1Q8NE71416
NRMBANF1O75531411
NRMGMLQ99445407

IntAct

191 interactions, top by confidence:

ABTypeScore
TRIM59NRMpsi-mi:“MI:0915”(physical association)0.780
NRMTRIM59psi-mi:“MI:0915”(physical association)0.780
TMUB1ERLIN2psi-mi:“MI:0914”(association)0.660
CREB3L1NRMpsi-mi:“MI:0915”(physical association)0.560
SUN2NRMpsi-mi:“MI:0915”(physical association)0.560
NRMSUN2psi-mi:“MI:0915”(physical association)0.560
NRMRTP4psi-mi:“MI:0915”(physical association)0.560
NRMPCDHGA4psi-mi:“MI:0915”(physical association)0.560
NRMEBPpsi-mi:“MI:0915”(physical association)0.560
NRMLEPROTL1psi-mi:“MI:0915”(physical association)0.560
NRMSLC39A2psi-mi:“MI:0915”(physical association)0.560
NRMAQP2psi-mi:“MI:0915”(physical association)0.560
NRMSLC6A15psi-mi:“MI:0915”(physical association)0.560
NRMGPR151psi-mi:“MI:0915”(physical association)0.560
NRMMRM1psi-mi:“MI:0915”(physical association)0.560
NRMTMX2psi-mi:“MI:0915”(physical association)0.560

BioGRID (79): SUN2 (Two-hybrid), CREB3L1 (Two-hybrid), TRIM59 (Two-hybrid), NRM (Affinity Capture-MS), CRNN (Affinity Capture-MS), NRM (Affinity Capture-MS), ZG16B (Affinity Capture-MS), NRM (Affinity Capture-MS), NRM (Affinity Capture-MS), NRM (Two-hybrid), NRM (Two-hybrid), NRM (Two-hybrid), NRM (Two-hybrid), NRM (Two-hybrid), NRM (Two-hybrid)

ESM2 similar proteins: A0JP80, A1A5Z0, A5D6W6, A7YWN2, B2MVP8, B6CZ46, L5KLU7, O42153, O75783, O75908, O77759, O88908, P58872, P58873, P86243, Q1HG44, Q1KZG0, Q1XHX8, Q32LM8, Q49LS7, Q52KL1, Q5CZN0, Q5KR61, Q5T197, Q5TM67, Q5XIL6, Q6AX73, Q6AZ83, Q6MG14, Q6NSQ9, Q6P5W5, Q767L9, Q7TNJ2, Q7TQM4, Q80YU0, Q86VD9, Q8AVI9, Q8CIP5, Q8IWX5, Q8IXM6

Diamond homologs: A0A0F6P9C0, B1WZQ6, O05883, P87014, Q1XHX8, Q5TM67, Q6MG14, Q767L9, Q89I98, Q89V40, Q8IXM6, Q8VC65, W6VBF4, Q1L911, Q296J9, Q32LM8, Q6GNM0, Q9VEG9, P32584

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

32 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance26
Likely benign5
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

714 predictions. Top by Δscore:

VariantEffectΔscore
6:30689449:CCAG:Cacceptor_gain1.0000
6:30689450:CAGC:Cacceptor_gain1.0000
6:30691147:T:TAdonor_gain1.0000
6:30688939:ATACC:Aacceptor_loss0.9900
6:30688940:TACC:Tacceptor_loss0.9900
6:30688943:C:Aacceptor_loss0.9900
6:30688944:T:Aacceptor_loss0.9900
6:30689450:CAG:Cacceptor_gain0.9900
6:30689453:C:CCacceptor_gain0.9900
6:30690254:T:Cacceptor_gain0.9900
6:30690847:C:CTdonor_gain0.9900
6:30690848:C:CTdonor_gain0.9900
6:30691103:T:TAdonor_gain0.9900
6:30691125:T:TAdonor_gain0.9900
6:30691126:C:Adonor_gain0.9900
6:30689448:ACCAG:Aacceptor_gain0.9800
6:30689449:CCAGC:Cacceptor_gain0.9800
6:30689451:AGC:Aacceptor_loss0.9800
6:30689452:GCTGT:Gacceptor_loss0.9800
6:30689453:CT:Cacceptor_loss0.9800
6:30689454:T:Aacceptor_loss0.9800
6:30690241:CAT:Cacceptor_gain0.9800
6:30690242:ATCT:Aacceptor_loss0.9800
6:30690244:C:CAacceptor_loss0.9800
6:30690244:C:CCacceptor_gain0.9800
6:30690245:T:Aacceptor_loss0.9800
6:30690254:T:TCacceptor_gain0.9800
6:30691090:C:CTdonor_gain0.9800
6:30690253:G:GCacceptor_gain0.9700
6:30690805:T:Adonor_gain0.9700

AlphaMissense

1644 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
6:30689321:G:CS154R0.998
6:30689321:G:TS154R0.998
6:30689323:T:GS154R0.998
6:30689279:T:AK168N0.997
6:30689279:T:GK168N0.997
6:30689304:T:AD160V0.997
6:30689338:A:GW149R0.997
6:30689338:A:TW149R0.997
6:30688828:A:GW208R0.996
6:30688828:A:TW208R0.996
6:30688898:C:AK184N0.996
6:30688898:C:GK184N0.996
6:30689280:T:AK168I0.996
6:30689287:C:GG166R0.996
6:30689304:T:GD160A0.995
6:30689305:C:GD160H0.994
6:30689303:G:CD160E0.993
6:30689303:G:TD160E0.993
6:30689305:C:AD160Y0.993
6:30689362:A:GC141R0.993
6:30689292:A:GL164P0.991
6:30688860:T:CH197R0.990
6:30690084:C:AR98M0.990
6:30688861:G:CH197D0.989
6:30689287:C:AG166C0.988
6:30689435:C:AW116C0.988
6:30689435:C:GW116C0.988
6:30688737:T:AD238V0.987
6:30688864:G:TR196S0.987
6:30690891:A:CF28L0.987

dbSNP variants (sampled 300 via entrez): RS1002322612 (6:30691176 T>C), RS1004005392 (6:30692238 C>T), RS1004067064 (6:30692936 G>A), RS1005031678 (6:30688402 T>G), RS1005569430 (6:30693096 G>A), RS1005683947 (6:30693374 C>G), RS1007075984 (6:30690353 G>A,T), RS1007429056 (6:30688859 G>A,T), RS1008082113 (6:30692072 A>G,T), RS1008460150 (6:30690191 G>A,T), RS1009918633 (6:30689893 T>G), RS1010610160 (6:30691915 C>G,T), RS1010887315 (6:30689617 G>C), RS1011795871 (6:30691443 G>A), RS1013104977 (6:30687795 C>T)

Disease associations

OMIM: gene MIM:620017 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

22 associations (top):

StudyTraitp-value
GCST003538_2Alcohol dependence symptom count3.000000e-10
GCST004521_114Autism spectrum disorder or schizophrenia3.000000e-17
GCST004521_117Autism spectrum disorder or schizophrenia3.000000e-15
GCST004521_121Autism spectrum disorder or schizophrenia3.000000e-13
GCST004521_132Autism spectrum disorder or schizophrenia2.000000e-09
GCST004521_171Autism spectrum disorder or schizophrenia4.000000e-14
GCST004521_2Autism spectrum disorder or schizophrenia2.000000e-16
GCST004521_209Autism spectrum disorder or schizophrenia5.000000e-16
GCST004521_210Autism spectrum disorder or schizophrenia5.000000e-15
GCST004521_211Autism spectrum disorder or schizophrenia5.000000e-15
GCST004521_263Autism spectrum disorder or schizophrenia7.000000e-17
GCST004521_265Autism spectrum disorder or schizophrenia7.000000e-14
GCST004521_269Autism spectrum disorder or schizophrenia7.000000e-11
GCST004521_295Autism spectrum disorder or schizophrenia6.000000e-18
GCST004521_3Autism spectrum disorder or schizophrenia2.000000e-15
GCST004521_48Autism spectrum disorder or schizophrenia1.000000e-09
GCST004521_56Autism spectrum disorder or schizophrenia1.000000e-22
GCST004521_70Autism spectrum disorder or schizophrenia8.000000e-20
GCST004521_79Autism spectrum disorder or schizophrenia1.000000e-16
GCST004861_77Itch intensity from mosquito bite2.000000e-08
GCST007326_6Number of sexual partners2.000000e-08
GCST008053_76Height2.000000e-09

EFO canonical traits (2, from GWAS)

EFO IDTrait name
EFO:0007835alcohol dependence measurement
EFO:0008377mosquito bite reaction itch intensity measurement

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

36 total (human), top 30 by PubMed support.

ChemicalActions (top 5)PubMed papers
sodium arseniteaffects expression, decreases expression, increases abundance, increases expression4
bisphenol Aaffects expression, decreases methylation2
Air Pollutantsdecreases expression, increases abundance2
Arsenicdecreases expression, increases abundance, increases expression2
GSK-J4decreases expression1
FR900359increases phosphorylation1
triphenyl phosphateaffects expression1
pirinixic acidaffects binding, decreases expression, increases activity1
beta-lapachonedecreases expression1
tris(1,3-dichloro-2-propyl)phosphatedecreases expression1
perfluorooctanoic aciddecreases expression1
zinc chromatedecreases expression, increases abundance1
2,3-bis(3’-hydroxybenzyl)butyrolactoneaffects cotreatment, increases expression1
phenethyl isothiocyanatedecreases expression1
chromium hexavalent iondecreases expression, increases abundance1
K 7174decreases expression1
jinfukangincreases expression1
(+)-JQ1 compounddecreases expression1
Resveratrolaffects cotreatment, increases expression1
Leflunomidedecreases expression1
Benzo(a)pyreneincreases expression1
Cadmiumdecreases expression, increases abundance1
Calcitriolaffects cotreatment, decreases expression1
Carbamazepineaffects expression1
Coumestrolincreases expression, affects cotreatment1
Dichlorodiphenyl Dichloroethyleneincreases expression1
Testosteroneaffects cotreatment, decreases expression1
Tetrachlorodibenzodioxinaffects expression1
Dronabinolincreases expression1
Thimerosaldecreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.